KERALA AYURVEDA
Back to Income Statement
|
KERALA AYURVEDA Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹120 Cr | ₹108 Cr | ₹93 Cr | ₹80 Cr | ₹62 Cr |
What is the latest Revenue of KERALA AYURVEDA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹120 Cr |
| Mar2024 | ₹108 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹80 Cr |
| Mar2021 | ₹62 Cr |
How is Revenue of KERALA AYURVEDA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹120 Cr | 11.57 | |
| Mar2024 | ₹108 Cr | 15.46 | |
| Mar2023 | ₹93 Cr | 16.25 | |
| Mar2022 | ₹80 Cr | 29.45 | |
| Mar2021 | ₹62 Cr | - | |
Compare Revenue of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹190.6 Cr | -2.4% | -11% | -66.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -2.4% |
-11% |
-66.2% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses